ADP is an important agonist for platelet activation and plays a major role in hemostasis and thrombosis. ADP causes platelets to change their shape, to aggregate, to release contents of granules, and to produce thromboxane A2, another potent agonist for platelets. The physiological effects and intracellular responses of ADP on platelets have been well characterized and the receptor mediating these effects has been cloned. However the molecular mechanism of these ADP-mediated physiological processes remains obscure. During the previous grant period, we have demonstrated three ADP receptor subtypes, P2Y1, P2Y12, and P2X1, on platelets and elucidated a number of signaling mechanisms in platelets. In this grant period, we propose to enhance our understanding by elucidating the molecular mechanisms of ADP-induced platelet activation. 1. We hypothesize that G protein-activated inwardly rectifying K+ channels play an important role in the Gi mediated effects on platelet fibrinogen receptor activation, platelet dense granule release, and thromboxane A2 generation. We will test this hypothesis by pharmacological approaches and by molecular genetic approaches. 2. We hypothesize that the functional P2Y12 receptor requires an environment of lipid microdomains, also known as lipid rafts. Our preliminary evidence indicates that the function of P2Y12 receptor, is selectively affected by cholesterol depletion. We will test our hypothesis and identify the basis for such requirement by biochemical and pharmacological approaches. 3. Platelets are known to express three receptors for ADP. We hypothesize that platelets express a low affinity ADP receptor that does not cause increases in intracellular calcium. We propose to provide evidence for this fourth ADP receptor on platelets by pharmacological and gene knockout approaches. 4. We hypothesize that distinct intracellular domains on P2Y1 and P2Y12 receptors couple to the Gq and Gi proteins. This hypothesis will be tested by the molecular and cell biological approaches to identify the G protein-coupling domains on the P2Y 1 and P2Y 12 receptors.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL060683-06
Application #
6682178
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Hasan, Ahmed AK
Project Start
1998-07-01
Project End
2007-06-30
Budget Start
2003-07-14
Budget End
2004-06-30
Support Year
6
Fiscal Year
2003
Total Cost
$376,250
Indirect Cost
Name
Temple University
Department
Physiology
Type
Schools of Medicine
DUNS #
057123192
City
Philadelphia
State
PA
Country
United States
Zip Code
19122
Liverani, Elisabetta; Rico, Mario C; Garcia, Analia E et al. (2013) Prasugrel metabolites inhibit neutrophil functions. J Pharmacol Exp Ther 344:231-43
Manne, Bhanu Kanth; Getz, Todd M; Hughes, Craig E et al. (2013) Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2). J Biol Chem 288:7717-26
Zhang, S; Ye, J; Zhang, Y et al. (2013) P2Y12 protects platelets from apoptosis via PI3k-dependent Bak/Bax inactivation. J Thromb Haemost 11:149-60
Garcia, Analia E; Rico, Mario C; Liverani, Elisabetta et al. (2013) Erosive arthritis and hepatic granuloma formation induced by peptidoglycan polysaccharide in rats is aggravated by prasugrel treatment. PLoS One 8:e69093
Kim, Soochong; Cipolla, Lina; Guidetti, Gianni et al. (2013) Distinct role of Pyk2 in mediating thromboxane generation downstream of both G12/13 and integrin ?IIb?3 in platelets. J Biol Chem 288:18194-203
Bynagari-Settipalli, Yamini S; Lakhani, Parth; Jin, Jianguo et al. (2012) Protein kinase C isoform ? negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets. Arterioscler Thromb Vasc Biol 32:1211-9
Zhang, Y; Ye, J; Hu, L et al. (2012) Increased platelet activation and thrombosis in transgenic mice expressing constitutively active P2Y12. J Thromb Haemost 10:2149-57
Getz, T M; Mayanglambam, A; Daniel, J L et al. (2011) Go6976 abrogates GPVI-mediated platelet functional responses in human platelets through inhibition of Syk. J Thromb Haemost 9:608-10
Bhavaraju, Kamala; Lakhani, Parth R; Dorsam, Robert T et al. (2011) G(12/13) signaling pathways substitute for integrin ?IIb?3-signaling for thromboxane generation in platelets. PLoS One 6:e16586
Garcia, Analia E; Mada, Sripal R; Rico, Mario C et al. (2011) Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis. PLoS One 6:e26035

Showing the most recent 10 out of 81 publications